The challenge of change: building Excellent launches in the post-pandemic environment
Key strategic considerations for pricing and market access
How pharmaceutical companies make clinical development location decisions, and what healthcare policy makers can do to attract commercial clinical investment.
How to deliver consistent launch performance in an increasingly complex world
The case for integration and focus
Five key focus areas for Life Sciences during and after the COVID-19 pandemic